Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Company Profile for Anadys Pharmaceuticals Inc.


Business Editors/Health/Medical Writers

SAN DIEGO--(BUSINESS WIRE)--Oct. 3, 2003

Anadys Pharmaceuticals Inc. (www.anadyspharma.com) is a biopharmaceutical company committed to advancing patient care by discovering, developing and commercializing novel and powerful anti-infective an·ti-in·fec·tive
adj.
Capable of preventing or counteracting infection.

n.
An anti-infective agent or drug.



anti-infective

1. counteracting infection.

2. a substance that counteracts infection.
 medicines. Our company utilizes an integrated drug discovery and development process based on several proprietary biological and chemical technologies. The approach is designed to advance a strong and continual pipeline of drug candidates into the clinic.


   Company:                Anadys Pharmaceuticals Inc.

   Headquarters Address:   9050 Camino Santa Fe
                           San Diego, CA 92121

   Main Telephone:         (858) 530-3600

   Type of Organization:   Private

   Industry:               Health: Biotechnology

   Key Executives:         CEO: Kleanthis Xanthopoulos
                           CSO: Steve Worland
                           Vice-President, Corporate Development:
                            Michael Kamdar

   Public Relations
     Contact:              Andre Basbaum
     Phone:                (858) 530-3621
     Email:                abasbaum@anadyspharma.com

   Investor Relations
     Contact:              Michael Kamdar
     Phone:                (858) 530-3600

COPYRIGHT 2003 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2003, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Oct 3, 2003
Words:130
Previous Article:Company Profile for IHL Consulting Group.
Next Article:Company Profile for Miikana Therapeutics.
Topics:



Related Articles
Anadys Announces Extension of Collaboration With Roche.
Anadys Appoints George A. Scangos to Board of Directors; Distinguished Pharmaceutical Executive to Provide Clinical Development, Commercial, and...
Anadys Forms Drug Discovery Collaboration with Daiichi; Daiichi Accesses Anadys' Drug Discovery Capabilities to Advance Key Research Efforts.
Anadys Achieves Research Milestone in Drug Discovery Collaboration With Amgen.
Anadys Announces Executive Promotion and Appointment of New Regulatory Affairs Post.
Anadys Pharmaceuticals and LG Life Sciences Announce Completion of Phase I/IIa Clinical Trial of ANA380 -LB80380- in Patients Chronically Infected...
Anadys Pharmaceuticals Announces Move to Facility Located in the Torrey Mesa Area, San Diego, California; State-of-the-Art, Former Syngenta Facility...
Anadys Pharmaceuticals Enters New Drug Discovery Collaboration with Roche; Second Alliance Builds on Success of Initial Collaboration.
The hepatitis C drug development pipeline.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles